Evidence map›Paper›PMID 20643727›Full record

ArticlePediatrics2010

Prevalence and complications of single-gene and chromosomal disorders in craniosynostosis.

Andrew O M Wilkie, Jo C Byren, Jane A Hurst, Jayaratnam Jayamohan, David Johnson, Samantha J L Knight, Tracy Lester, Peter G Richards, Stephen R F Twigg, Steven A Wall

Open access · greenAbstract read
In one paragraph

Article in Pediatrics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 118 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed, 3 pooled it
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 3 syntheses or guidelines pooled it, 287 citations in OpenAlex.

  1. Genetics versus environment in the pathophysiology of sagittal synostosis.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Pooled it
  2. Pooled it
  3. The role of pathogenic TCF12 variants in children with coronal craniosynostosis-a systematic review with addition of two novel cases.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Pooled it
  4. Trial
  5. Article
  6. Endoscopic management of unilateral coronal synostosis: impact on the fronto-orbital growth.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Genetic Testing in Craniofacial Care: Development of Algorithms for Testing Patients with Orofacial Clefting, Branchial Arch Anomalies, and Craniosynostosis.The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association · 2025
    Article
  12. Article
  13. Orthoptic findings in trigonocephaly patients after completed visual development.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Article
  14. Article
  15. New CRISPR/Cas9-based Fgfr2Journal of molecular medicine (Berlin, Germany) · 2024
    Article
  16. Review
  17. Macrocephaly and Finger Changes: A Narrative Review.International journal of molecular sciences · 2024
    Review
  18. Article
  19. Article
  20. Regulatory elements inGenetics in medicine open · 2024
    Article

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Andrew O M WilkieWeatherall Institute of Molecular Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. awilkie@hammer.imm.ox.ac.uk
Jo C Byren
Jane A Hurst
Jayaratnam Jayamohan
David Johnson
Samantha J L Knight
Tracy Lester
Peter G Richards
Stephen R F Twigg
Steven A Wall
John Radcliffe Hospital · GBCentre for Human Genetics · GBInstitute of Molecular Medicine · INNational Health Service · GB

Funding

Wellcome Trust 075491Wellcome Trust 078666
6 · The paper itself

Abstract

objectivesWe describe the first cohort-based analysis of the impact of genetic disorders in craniosynostosis. We aimed to refine the understanding of prognoses and pathogenesis and to provide rational criteria for clinical genetic testing.

methodsWe undertook targeted molecular genetic and cytogenetic testing for 326 children who required surgery because of craniosynostosis, were born in 1993-2002, presented to a single craniofacial unit, and were monitored until the end of 2007.

resultsEighty-four children (and 64 relatives) had pathologic genetic alterations (86% single-gene mutations and 14% chromosomal abnormalities). The FGFR3 P250R mutation was the single largest contributor (24%) to the genetic group. Genetic diagnoses accounted for 21% of all craniosynostosis cases and were associated with increased rates of many complications. Children with an initial clinical diagnosis of nonsyndromic craniosynostosis were more likely to have a causative mutation if the synostoses were unicoronal or bicoronal (10 of 48 cases) than if they were sagittal or metopic (0 of 55 cases; P = .0003). Repeat craniofacial surgery was required for 58% of children with single-gene mutations but only 17% of those with chromosomal abnormalities (P = .01).

conclusionsClinical genetic assessment is critical for the treatment of children with craniosynostosis. Genetic testing of nonsyndromic cases (at least for FGFR3 P250R and FGFR2 exons IIIa/c) should be targeted to patients with coronal or multisuture synostoses. Single-gene disorders that disrupt physiologic signaling in the cranial sutures often require reoperation, whereas chromosomal abnormalities follow a more-indolent course, which suggests a different, secondary origin of the associated craniosynostosis.

Indexed as

Chromosome AberrationsCraniosynostosesCytogenetic AnalysisExonsGenetic Diseases, InbornHumansInfantInfant, NewbornMolecular BiologyNeurosurgical ProceduresPlastic Surgery ProceduresPoint MutationPrevalenceReceptor, Fibroblast Growth Factor, Type 3Signal TransductionFGFR3 protein, humanReceptor, Fibroblast Growth Factor, Type 3

Identifiers

PMID20643727
PMCPMC3535761
OpenAlexW1989045574

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.